Abstract
Organoid technologies are a potent tool for investigating human biology, modelling diseases and developing novel therapies. In this Viewpoint, experts in metabolic and endocrine research in the brain, pituitary, skeletal muscle, bone and gastrointestinal system discuss how organoids and related bioengineered systems are currently used in their field and how innovations in these technologies could transform future research.
| Original language | English |
|---|---|
| Pages (from-to) | 195-201 |
| Number of pages | 7 |
| Journal | Nature Reviews. Endocrinology |
| Volume | 20 |
| Issue number | 4 |
| Early online date | 5 Jan 2024 |
| DOIs | |
| Publication status | Published - Apr 2024 |
Funding
P.M.G. is cross-appointed to the Donnelly Centre and to the Department of Cell and Systems Biology at the University of Toronto. H.H.N. is supported by grants from the Agency for Science, Technology and Research (A*STAR) and the National Medical Research Council of Singapore. H.H.N. is grateful to Dr Alfred Sun (Duke-NUS Medical School) for discussion during the preparation of this manuscript. H.V. was supported by grants from the KU Leuven Research Fund and the Fund for Scientific Research (FWO) – Flanders (Belgium).
| Funders | Funder number |
|---|---|
| Katholieke Universiteit Leuven | |
| Agency for Science, Technology and Research (A*STAR) | |
| National Health and Medical Research Council | |
| Fonds De La Recherche Scientifique - FNRS | |
| Fonds Wetenschappelijk Onderzoek |
